Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-05-02
2009-06-30
Rao, Manjunath N (Department: 1647)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C435S069100, C530S399000
Reexamination Certificate
active
07553813
ABSTRACT:
The invention relates to the method for treatment, diagnosis and prevention of diseases related to fetal growth and placental insufficiency and comprises methods including inhibiting or increasing relaxin synthesis, relaxin receptor synthesis, relaxin binding to the relaxin receptor, and relaxin receptor activity. The invention also relates to screening assays to identify compounds that modulate relaxin and/or relaxin receptor activity. The invention further relates to gene therapy methods utilizing relaxin and relaxin-related sequences for the treatment and prevention of diseases related to fetal growth and placental insufficiency.
REFERENCES:
patent: 4109496 (1978-08-01), Alleman et al.
patent: 4215051 (1980-07-01), Schroeder et al.
patent: 4267101 (1981-05-01), Bigazzi
patent: 4376110 (1983-03-01), David et al.
patent: 4683202 (1987-07-01), Mullis
patent: 4758516 (1988-07-01), Hudson et al.
patent: 4816397 (1989-03-01), Boss et al.
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 4835251 (1989-05-01), Burnier et al.
patent: 4871670 (1989-10-01), Hudson et al.
patent: 4873191 (1989-10-01), Wagner et al.
patent: 4946778 (1990-08-01), Ladner et al.
patent: 5023321 (1991-06-01), Hudson et al.
patent: 5075217 (1991-12-01), Weber
patent: 5179195 (1993-01-01), Hudson et al.
patent: 5225539 (1993-07-01), Winter
patent: 5320953 (1994-06-01), Hudson et al.
patent: 5326694 (1994-07-01), Hudson et al.
patent: 5364759 (1994-11-01), Caskey et al.
patent: 5399349 (1995-03-01), Paunescu et al.
patent: 5420111 (1995-05-01), Gluckman et al.
patent: 5451572 (1995-09-01), Cipolla et al.
patent: 5460959 (1995-10-01), Mulligan et al.
patent: 5464756 (1995-11-01), Henner et al.
patent: 5545806 (1996-08-01), Lonberg et al.
patent: 5569825 (1996-10-01), Lonberg et al.
patent: 5585089 (1996-12-01), Queen et al.
patent: 5625126 (1997-04-01), Lonberg et al.
patent: 5633425 (1997-05-01), Lonberg et al.
patent: 5661016 (1997-08-01), Lonberg et al.
patent: 5811395 (1998-09-01), Schwabe et al.
patent: 5911997 (1999-06-01), Schwabe et al.
patent: 5945402 (1999-08-01), Cipolla et al.
patent: 5952296 (1999-09-01), Bigazzi
patent: 5972621 (1999-10-01), Tartaglia et al.
patent: 6211147 (2001-04-01), Unemori
patent: 6723702 (2004-04-01), Conrad et al.
patent: 6780836 (2004-08-01), Unemori
patent: 7363076 (2008-04-01), Yun et al.
patent: 2002/0123455 (2002-09-01), Ryan et al.
patent: 2004/0192606 (2004-09-01), Unemori
patent: 2004/0266685 (2004-12-01), Conrad et al.
patent: 2005/0026822 (2005-02-01), Tregear et al.
patent: 2005/0143299 (2005-06-01), Bigazzi et al.
patent: 2005/0153885 (2005-07-01), Yun et al.
patent: 2005/0240241 (2005-10-01), Yun et al.
patent: 2005/0256028 (2005-11-01), Yun et al.
patent: 2006/0034847 (2006-02-01), Yun et al.
patent: 2006/0247163 (2006-11-01), Unemori
patent: 2006/0247172 (2006-11-01), Unemori
patent: 2007/0004619 (2007-01-01), Del Borgo et al.
patent: 171494 (1986-02-01), None
patent: 173496 (1986-02-01), None
patent: 0407401 (1996-04-01), None
patent: 0845992 (2000-11-01), None
patent: 1434599 (2003-04-01), None
patent: 1641824 (2004-12-01), None
patent: 1696948 (2005-07-01), None
patent: 1753449 (2005-12-01), None
patent: 0675732 (2006-06-01), None
patent: 1253929 (2007-05-01), None
patent: WO 86/01533 (1986-03-01), None
patent: WO 88/09810 (1988-12-01), None
patent: WO-89/07945 (1989-09-01), None
patent: WO 89/10134 (1989-11-01), None
patent: WO-95/03822 (1995-02-01), None
patent: WO-97/06814 (1997-02-01), None
patent: WO-01/58468 (2001-08-01), None
patent: WO-03/030930 (2003-04-01), None
patent: WO-2004/113381 (2004-12-01), None
patent: WO-2005/060991 (2005-07-01), None
patent: WO-2005/115435 (2005-12-01), None
Hayes et al. “Implantation and pregnancy following In Vitro Fertilization and the effect of recombinant human relaxin administration inMacaca fascilaris”, 71, Biology of Reproduction, 1591-1597 (2004).
Ergaz et al. “Intrauterine growth restriction-etiology and consequences: What do we know about the human situation and experimental animal models?”, 20, Reproductive Toxicology 301-322 (2005).
Chen, et al., The pharmacokinetics and absorption of recombinant human relaxin in nonpregnant rabbits and rhesus in non pregnant rabbits and rhesus monkeys after intravenous and intravaginal administration, 1993, Pharmaceutical Research, vol. 10, No. 3, pp. 223-227.
Gagnon, R. Placental insufficiency and its consequences, 2003, European Journal of Obstetrics and Gynecology and Reproductive Biology, 2003, vol. 110, pp. S99-S107.
Golub et al., Twelve-month evaluation of rhesus monkey dams and infants after relaxin (HRLX-2) infusion in late pregnancy, 1996, Reproductive Toxicology, vol. 10, No. 1, pp. 29-36.
Adham, et al., “Cloning Of A Cdna For A Novel Insulin-Like Hormone Of The Testicular Leydig Cells,”J. Biol. Chem. 268:26668-26672 (1993).
Bartsch, et al., “Relaxin Signalling Links Tyrosine Phosphorylation To Phosphodiesterase And Adenylyl Cyclase Activity,”Mol. Hum. Reprod. 7:799-809 (2001).
Bathgate, et al., “Human Relaxin Gene 3 (H3) and the Equivalent Mouse Relaxin (M3) Gene,”J Biol. Chem. 277(2):1148-1157 (2002).
Benson and Doubilet “Sonographic Prediction Of Gestational Age: Acccuracy Of Second- And Third-Trimester Fetal Measurements,”AJR Am. J. Roentgenol. 157:1275-1277 (1991).
Bullesbach and Schwabe, “Specific,.High Affinity Relaxin-like Factor Receptors,”J. Biol. Chem. 274:22354-22358 (1999).
Chien, et al., “The Two-Hybrid System: A Method To Identify And Clone Genes For Proteins That Interact With A Protein Of Interest,”Proc. Natl. Acad. Sci. USA88:9578-9582 (1991).
Cote, et al., “Generation Of Human Monoclonal Antibodies Reactive With Cellular Antigens,”Proc. Natl. Acad. Sci. USA80:2026-2030 (1983).
Danielson, et al., “Relaxin Is A Potent Renal Vasodilator In Conscious Rats,”J. Clin. Invest. 103:525-533 (1999).
Dokras, et al., “Regulation of Human Cytotrophoblast Morphogenesis by Hepatocyte Growth Factor/Scatter Factor,”Biol Reprod. 65:1278-1288 (2001).
Dschietzig, et al., “Relaxin, a Pregnancy Hormone, Is a Functional Endothelin-1 Antagonist,”Circ. Res. 92:32-40 (2003).
Frackelton, et al., “Characterization And Use Of Monoclonal Antibodies For Isolation Of Phosphotyrosyl Proteins From Retrovirus-Transformed Cells And Growth Factor-Stimulated Cells,”Mol. Cell. Biol. 3:1343-1352 (1983).
Greenspan and Bona, “Idiotypes: Structure And Immunogenicity,”FASEB J7:437-444 (1993).
Hudson, et al., “Relaxin Gene Expression In Human Ovaries And The Predicted Structure Of A Human Preprorelaxin By Analysis Of cDNA Clones,”Embo. J. 3(10):2333-2339 (1984).
Huston, et al., “Parathyroid Hormone Modulates Transforming Growth Factor β Activity and Binding in Osteoblast-Enriched Cell Cultures from Fetal Rat Parietal Bone,”Proc, Natl. Acad. Sci. USA85:5879-5883 (1988).
Inoue, et al. “Synthesis And Hybridization Studies On Two Complementary Nona(2′-O-Methyl)Ribonucleotides,”Nucl. Acids Res. 15:6131-6148 (1987).
Inouye and Inouye, “Up-Promoter Mutations In The Lpp Gene OfEscherichia coli,”Nucleic Acids Res. 13:3101-3109 (1985).
Ivell, “Immunoexpression Of The Relaxin Receptor LGR7 In Breast And Uterine Tissues Of Humans And Primates,” ReprodBiol Endocrinol1:114 (2003).
Kauma, et al., “Hepatocyte Growth Factor Stimulates Trophoblast Invasion: A Potential Mechanism for Abnormal Placentation in Preeclampsia,”J Clin Endocrinol Metab84:4092-4096.
Kumagai, et al., “INSL3/Leydig Insulin-Like Peptide Activates The LGR8 Receptor Important In Testis Descent,”J BiolChem 277:31283-31286 (2002).
Lakso, et al., “Targeted Oncogene Activation by Site-Specific Recombination in Transgenic Mice,”Proc. Natl. Acad Sci. USA89:6232-6236 (1992).
Lee, et al., “International Small for Gestational Age Advisory Board Consensus Development Conference Statement: Management of Short Children Bo
Corthera, Inc.
Dang Ian
Morrison & Foerster / LLP
Rao Manjunath N
LandOfFree
Methods and compositions for control of fetal growth via... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for control of fetal growth via..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for control of fetal growth via... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4130959